Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Standex International Corporation (NYSE: SXI) SEC filings page provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Standex’s financial performance, governance practices, executive compensation, and shareholder matters.
Standex submits a variety of forms, including Form 8-K current reports and its DEF 14A definitive proxy statement. Recent Form 8-K filings have covered topics such as the announcement of quarterly earnings, the results of the Annual Meeting of Shareholders, and changes in executive roles. Through these reports, investors can review information on segment performance across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions, as well as commentary on revenue, margins, and capital allocation.
The company’s definitive proxy statement describes board leadership structure, board committees, strategy and risk oversight, ESG strategy and risks, director compensation, director independence, and stock ownership. It also details the items presented to shareholders for voting, including director elections, advisory votes on executive compensation, and ratification of the independent auditors.
On this page, filings are updated as they are made available on EDGAR. AI-powered tools summarize key points from lengthy documents, helping users quickly identify topics such as shareholder vote outcomes, executive compensation disclosures, and significant corporate events reported on Form 8-K. Investors can use these summaries alongside the full-text filings to better understand Standex’s regulatory reporting and governance framework.
Standex International (SXI)11/10/2025. The filing shows an acquisition of 630 shares of common stock from a restricted stock grant, with 630 shares beneficially owned directly after the transaction.
The officer also received 378 Performance Share Units that cliff vest after a three‑year period, with the ultimate payout ranging from 0% to 250% of the award based on company performance metrics. In addition, 378 Restricted Stock Units were granted, scheduled to vest one‑third on August 23, 2026, one‑third on August 23, 2027, and one‑third on August 23, 2028.
Standex International (SXI) filed a Form 3 for a new insider. The reporting person is an officer, listed as Chief HR Officer & VP, with an event date of 11/10/2025. The filing states that no securities are beneficially owned by the officer at this time. This is an initial ownership report and reflects that the insider held no Standex stock or derivative securities when the reporting obligation began.
Standex International (SXI)November 10, 2025. She will transition to a role focused on executive coaching and leadership development, supporting an organizational need while addressing a significant health challenge.
Effective the same date, the Board appointed Michelle Newbury as Chief Human Resources Officer. Newbury, age 46, will lead global HR strategy, including talent management, organizational development, compensation and benefits, diversity and inclusion, and employee engagement initiatives.
Standex International (SXI)November 5, 2025, the reporting person sold 650 shares of common stock at a weighted average price of $233.37.
After the transaction, the insider beneficially owns 5,047 shares, held directly. The filing notes the sale occurred in multiple trades within a price range of $232.91 to $233.865, and detailed trade breakdowns are available upon request.
SXI: A holder filed a Form 144 notice to sell up to 650 shares of common stock. The filing lists an aggregate market value of $151,714.10, an approximate sale date of 11/05/2025, and identifies Fidelity Brokerage Services LLC as broker, with sales on the NYSE.
The shares were acquired via restricted stock vesting from the issuer on 10/26/2024 as compensation. Shares outstanding were 12,116,999; this is a baseline figure, not the amount being offered.
Standex International (SXI) executive reported an insider sale. The Vice President/CFO/Treasurer sold 1,823 shares of common stock on 11/04/2025, coded S (sale) on Form 4. The transaction was reported at a weighted average price of $230.12, with individual trades executed between $229.66 and $230.23.
Following the sale, the reporting person directly beneficially owns 9,341 shares. The filing notes the seller will provide full pricing breakdowns upon request.
SXI filed a Form 144 indicating a proposed sale of up to 1,823 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/04/2025 and an aggregate market value of $419,560.24.
The shares to be sold were acquired on 08/23/2025 via restricted stock vesting as compensation. Shares outstanding were 12,116,999.
Recent insider activity disclosed in the notice shows sales by Ademir Sarcevic over the past three months: 3,047 shares on 08/06/2025 for $584,446.61 and 1,085 shares on 08/26/2025 for $227,739.90. A Form 144 is a notice of potential sales by affiliates and does not obligate a sale to occur.
Standex International (SXI) reported an initial insider ownership filing. The company’s Chief Strategy Officer filed a Form 3 effective 10/27/2025, disclosing 5,697 shares of common stock, which includes 118 restricted shares subject to vesting.
The filing also lists derivative awards: phantom stock units tied to common stock of 161, 246, 352, 436, and 483 shares, and restricted stock units of 291 and 483 shares. Footnotes state phantom units vest after three years under the Management Stock Purchase Plan, performance share units cliff vest after a three‑year period subject to metrics, and RSUs vest one‑third annually.
Standex International Corporation reported the results of its Annual Meeting of Stockholders. Shareholders elected two directors to three-year terms ending at the 2028 annual meeting: Thomas E. Chorman (For: 9,623,949; Against: 1,253,659; Abstain: 1,454) and Andy L. Nemeth (For: 10,859,557; Against: 17,250; Abstain: 2,255).
Stockholders approved the advisory vote on executive compensation with 10,660,832 votes For, 213,117 Against, and 5,113 Abstain. They also ratified Deloitte & Touche LLP as the Company’s independent public accountants for the fiscal year ending June 30, 2026, with 10,943,594 votes For, 359,021 Against, and 1,619 Abstain. A total of 11,304,234 common shares were represented at the meeting.
Standex International (SXI) reported Q1 FY2026 results for the three months ended September 30, 2025. Net sales were $217.4 million, up from $170.5 million, led by Electronics at $110.6 million and Engraving at $35.8 million. Diluted EPS was $1.25 versus $1.53 a year ago as expenses increased.
Operating income was $29.6 million and included $6.0 million of restructuring costs and $0.4 million of acquisition costs. Interest expense rose to $8.9 million from $1.0 million, reducing income from continuing operations to $15.8 million. Cash from operations was $16.8 million. Cash and equivalents were $98.7 million, and long‑term debt was $544.6 million.
The company advanced integration of recent deals: McStarlite (cash consideration $57.0 million net of cash acquired) and the Amran/Narayan Group (final allocation: identifiable intangibles $136.0 million, goodwill $298.4 million). An interest rate swap effective August 30, 2025 fixes $225 million of borrowings at 3.48% through August 30, 2028. A quarterly dividend of $0.32 per share was declared.